BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3901485)

  • 21. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis, staging, and classification of bladder tumors.
    Cummings KB
    Semin Urol; 1983 Feb; 1(1):7-14. PubMed ID: 6679097
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
    Coblentz TR; Mills SE; Theodorescu D
    Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathology and classification of urinary bladder carcinoma.
    Friedell GH; Bell JR; Burney SW; Soto EA; Tiltman AJ
    Urol Clin North Am; 1976 Feb; 3(1):53-70. PubMed ID: 936368
    [No Abstract]   [Full Text] [Related]  

  • 26. The pathogenesis of bladder cancer.
    Friedell GH; Jacobs JB; Nagy GK; Cohen SM
    Am J Pathol; 1977 Nov; 89(2):431-42. PubMed ID: 920778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [So-called "superficial" bladder tumors. Which classification in 2003? Part 1: Papillary tumors].
    Billerey C; Sibony M
    Ann Pathol; 2003 Feb; 23(1):21-33. PubMed ID: 12743497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Superficial tumor of the bladder with associated carcinoma in situ: new occurrences and increase of tumor stage].
    Ojea Calvo A; Nogueira March JL; Figueiredo L; Jamardo D; Benavente J; Castro M
    Actas Urol Esp; 1991; 15(2):139-42. PubMed ID: 1807107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraepithelial lesions of urinary bladder: morphologic considerations.
    Murphy WM; Busch C; Algaba F
    Scand J Urol Nephrol Suppl; 2000; (205):67-81. PubMed ID: 11144906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses.
    Garbar C; Mascaux C; Wespes E
    Cytopathology; 2007 Apr; 18(2):79-83. PubMed ID: 17397491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
    Bittard H; Lamy B; Billery C
    J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bladder cancer: clinical and pathological profile.
    Lopez-Beltran A
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):95-109. PubMed ID: 18815924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of exfoliative cytology of the urinary bladder in occult bladder cancer and in the control of treated cancers].
    Schmitz A; Meyer U; Kierfeld G; Küchemann K
    Urologe A; 1984 Sep; 23(5):278-80. PubMed ID: 6542269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the diagnosis of urothelial neoplasia.
    Crissman JD; Zarbo RJ; Johnson T; Babu VR; Sarkar FH; Miles BJ; Cerny JC
    Henry Ford Hosp Med J; 1989; 37(1):19-23. PubMed ID: 2670840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
    Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
    J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in the mechanical integration of transitional epithelial cells and in the immune status of patients with bladder tumors].
    Bocharova OA; Serebriakova RV; Golubeva VA; Figurin KM; Bukharkin BV; Bodrova NB; Matveev BP; Baryshnikov AIu
    Urol Nefrol (Mosk); 1994; (3):27-30. PubMed ID: 8079407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histogenesis of urinary bladder cancer induced in rats by bracken fern.
    Pamukcu AM; Ertürk E; Yalçiner S; Bryan GT
    Invest Urol; 1976 Nov; 14(3):213-8. PubMed ID: 992973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.